Human Phenotype Ontology 
Grandparent Node:
expand
Abnormality of the pituitary gland (HP:0012503)help
Parent Node:
expand
Abnormality of the anterior pituitary (HP:0011747)help
..Starting node
..expand
Hyperpituitarism (HP:0010514)help
Term ID: 10514
Name: Hyperpituitarism
Synonym:
Definition: Hypersecretion of one or more pituitary hormones. This can occur in conditions in which deficiency in the target organ leads to decreased hormonal feedback, or as a primary condition most usually in connection with a pituitary adenoma.
Comments:
Reference: HP:0010514
Genes and Diseases:
 
       Child Nodes:
........expandIncreased circulating gonadotropin level (HP:0000837) help
................... HP:0008232 Elevated circulating follicle stimulating hormone level
................... HP:0011969 Elevated circulating luteinizing hormone level
........expandGrowth hormone excess (HP:0000845) help
........expandProlactin excess (HP:0000870) help
........expandAdrenocorticotropic hormone excess (HP:0011749) help

 Sister Nodes: 
..expandAnterior pituitary dysgenesis (HP:0010625) help
..expandEctopic anterior pituitary gland (HP:0012731) help
..expandHypopituitarism (HP:0040075) help
..expandNeoplasm of the anterior pituitary (HP:0011750) help
..expandPituitary calcification (HP:0010513) help
..expandPituitary resistance to thyroid hormone (HP:0008227) help
InputHPO IDHPO termDistanceGeneGene id entrezHGNC IDDiseaseIdDiseaseNameFrequencyOnsetHGMD variantsClinVar variants
 
HPO disease - gene - phenotype typical associations:
 
HPO disease - gene - phenotype less frequent non-typical associations:
HP:0010514HP:0010514Hyperpituitarism0ABCD1 CL E G H21561ORPHA:139399Adrenomyeloneuropathy135
HP:0010514HP:0010514Hyperpituitarism0AIP CL E G H9049358ORPHA:963Acromegaly95
HP:0010514HP:0010514Hyperpituitarism0AIP CL E G H9049358OMIM:102200Pituitary adenoma, growth hormone-secreting, 195
HP:0010514HP:0010514Hyperpituitarism0AIP CL E G H9049358ORPHA:99725Pituitary gigantism95
HP:0010514HP:0010514Hyperpituitarism0AIP CL E G H9049358ORPHA:2965Prolactinoma95
HP:0010514HP:0010514Hyperpituitarism0AKT1 CL E G H207391ORPHA:2495Meningioma54
HP:0010514HP:0010514Hyperpituitarism0AR CL E G H367644OMIM:300068Androgen insensitivity syndrome125
HP:0010514HP:0010514Hyperpituitarism0AR CL E G H367644ORPHA:99429Complete androgen insensitivity syndrome125
HP:0010514HP:0010514Hyperpituitarism0AR CL E G H367644ORPHA:90797Partial androgen insensitivity syndrome125
HP:0010514HP:0010514Hyperpituitarism0BAP1 CL E G H8314950ORPHA:2495Meningioma184
HP:0010514HP:0010514Hyperpituitarism0BMP15 CL E G H92101068ORPHA:24346,XX gonadal dysgenesis16
HP:0010514HP:0010514Hyperpituitarism0BMPR1B CL E G H6581077OMIM:609441Acromesomelic dysplasia, Demirhan type90
HP:0010514HP:0010514Hyperpituitarism0BNC1 CL E G H6461081ORPHA:24346,XX gonadal dysgenesis
HP:0010514HP:0010514Hyperpituitarism0BNC1 CL E G H6461081OMIM:618723PREMATURE OVARIAN FAILURE 16; POF16
HP:0010514HP:0010514Hyperpituitarism0BRAF CL E G H6731097ORPHA:54595Craniopharyngioma276
HP:0010514HP:0010514Hyperpituitarism0C14ORF39 CL E G H31776119849ORPHA:399805Male infertility with azoospermia or oligozoospermia due to single gene mutation
HP:0010514HP:0010514Hyperpituitarism0C14ORF39 CL E G H31776119849OMIM:619203PREMATURE OVARIAN FAILURE 18; POF18
HP:0010514HP:0010514Hyperpituitarism0CBX2 CL E G H847331552OMIM:61308046XY sex reversal 53
HP:0010514HP:0010514Hyperpituitarism0CCDC34 CL E G H9105725079ORPHA:399805Male infertility with azoospermia or oligozoospermia due to single gene mutation
HP:0010514HP:0010514Hyperpituitarism0CDH23 CL E G H6407213733ORPHA:2965Prolactinoma636
HP:0010514HP:0010514Hyperpituitarism0CDH23 CL E G H6407213733ORPHA:91347TSH-secreting pituitary adenoma636
HP:0010514HP:0010514Hyperpituitarism0CDKN1A CL E G H10261784ORPHA:652Multiple endocrine neoplasia type 12
HP:0010514HP:0010514Hyperpituitarism0CDKN1B CL E G H10271785ORPHA:652Multiple endocrine neoplasia type 1102
HP:0010514HP:0010514Hyperpituitarism0CDKN1B CL E G H10271785ORPHA:276152Multiple endocrine neoplasia type 4102
HP:0010514HP:0010514Hyperpituitarism0CDKN1B CL E G H10271785OMIM:610755Multiple endocrine neoplasia, type IV102
HP:0010514HP:0010514Hyperpituitarism0CDKN2B CL E G H10301788ORPHA:652Multiple endocrine neoplasia type 11
HP:0010514HP:0010514Hyperpituitarism0CDKN2C CL E G H10311789ORPHA:652Multiple endocrine neoplasia type 1
HP:0010514HP:0010514Hyperpituitarism0CFTR CL E G H10801884ORPHA:399805Male infertility with azoospermia or oligozoospermia due to single gene mutation1371
HP:0010514HP:0010514Hyperpituitarism0CNBP CL E G H755513164OMIM:602668Dystrophia myotonica 21
HP:0010514HP:0010514Hyperpituitarism0CTNNB1 CL E G H14992514ORPHA:54595Craniopharyngioma88
HP:0010514HP:0010514Hyperpituitarism0CYB5A CL E G H15282570ORPHA:9079646,XY disorder of sex development due to isolated 17,20-lyase deficiency2
HP:0010514HP:0010514Hyperpituitarism0CYP11A1 CL E G H15832590ORPHA:16855846,XY disorder of sex development-adrenal insufficiency due to CYP11A1 deficiency31
HP:0010514HP:0010514Hyperpituitarism0CYP11A1 CL E G H15832590OMIM:613743Adrenal insufficiency, congenital, with 46XY sex reversal, partial or complete31
HP:0010514HP:0010514Hyperpituitarism0CYP11A1 CL E G H15832590ORPHA:289548Inherited isolated adrenal insufficiency due to partial CYP11A1 deficiency31
HP:0010514HP:0010514Hyperpituitarism0CYP17A1 CL E G H15862593ORPHA:9079646,XY disorder of sex development due to isolated 17,20-lyase deficiency53
HP:0010514HP:0010514Hyperpituitarism0CYP17A1 CL E G H15862593ORPHA:90793Congenital adrenal hyperplasia due to 17-alpha-hydroxylase deficiency53
HP:0010514HP:0010514Hyperpituitarism0DHH CL E G H508462865ORPHA:16856346,XY gonadal dysgenesis-motor and sensory neuropathy syndrome21
HP:0010514HP:0010514Hyperpituitarism0DHX37 CL E G H5764717210OMIM:27325046, XY sex reversal 112
HP:0010514HP:0010514Hyperpituitarism0DHX37 CL E G H5764717210ORPHA:25151046,XY partial gonadal dysgenesis2
HP:0010514HP:0010514Hyperpituitarism0DIAPH2 CL E G H17302877OMIM:300511Premature ovarian failure 2A6
HP:0010514HP:0010514Hyperpituitarism0DMRT3 CL E G H5852413909ORPHA:25151046,XY partial gonadal dysgenesis1
HP:0010514HP:0010514Hyperpituitarism0ERCC6 CL E G H20743438OMIM:616946PREMATURE OVARIAN FAILURE 11; POF11199
HP:0010514HP:0010514Hyperpituitarism0ESR1 CL E G H20993467ORPHA:785Estrogen resistance syndrome13
HP:0010514HP:0010514Hyperpituitarism0ESR2 CL E G H21003468OMIM:618187Ovarian dysgenesis 8
HP:0010514HP:0010514Hyperpituitarism0FANCM CL E G H5769723168ORPHA:399805Male infertility with azoospermia or oligozoospermia due to single gene mutation107
HP:0010514HP:0010514Hyperpituitarism0FANCM CL E G H5769723168OMIM:618086Spermatogenic failure 28107
HP:0010514HP:0010514Hyperpituitarism0FGD1 CL E G H22453663OMIM:305400Aarskog-Scott syndrome62
HP:0010514HP:0010514Hyperpituitarism0FIGLA CL E G H34401824669OMIM:612310PREMATURE OVARIAN FAILURE 6; POF617
HP:0010514HP:0010514Hyperpituitarism0FKBP6 CL E G H84683722OMIM:620103
HP:0010514HP:0010514Hyperpituitarism0FMR1 CL E G H23323775OMIM:311360Premature ovarian failure 130
HP:0010514HP:0010514Hyperpituitarism0FOXL2 CL E G H6681092OMIM:110100Blepharophimosis, epicanthus inversus, and ptosis92
HP:0010514HP:0010514Hyperpituitarism0FOXL2 CL E G H6681092ORPHA:572333Blepharophimosis-ptosis-epicanthus inversus syndrome plus92
HP:0010514HP:0010514Hyperpituitarism0FSHB CL E G H24883964OMIM:229070Hypogonadotropic hypogonadism 24 without anosmia23
HP:0010514HP:0010514Hyperpituitarism0FSHR CL E G H24923969ORPHA:24346,XX gonadal dysgenesis50
HP:0010514HP:0010514Hyperpituitarism0FSHR CL E G H24923969OMIM:233300Ovarian dysgenesis 150
HP:0010514HP:0010514Hyperpituitarism0FSHR CL E G H24923969ORPHA:64739Ovarian hyperstimulation syndrome50
HP:0010514HP:0010514Hyperpituitarism0GATA4 CL E G H26264173ORPHA:25151046,XY partial gonadal dysgenesis87
HP:0010514HP:0010514Hyperpituitarism0GCNA CL E G H9395315805OMIM:301077SPERMATOGENIC FAILURE, X-LINKED, 4; SPGFX4
HP:0010514HP:0010514Hyperpituitarism0GDF9 CL E G H26614224OMIM:618014Premature ovarian failure 142
HP:0010514HP:0010514Hyperpituitarism0GNAS CL E G H27784392ORPHA:562McCune-Albright syndrome101
HP:0010514HP:0010514Hyperpituitarism0GNAS CL E G H27784392OMIM:174800McCune-Albright syndrome, somatic, mosaic101
HP:0010514HP:0010514Hyperpituitarism0GPR101 CL E G H8355014963ORPHA:963Acromegaly5
HP:0010514HP:0010514Hyperpituitarism0GPR101 CL E G H8355014963OMIM:300942Chromosome Xq26.3 duplication syndrome5
HP:0010514HP:0010514Hyperpituitarism0GPR101 CL E G H8355014963OMIM:300943PITUITARY ADENOMA 2, GROWTH HORMONE-SECRETING; PITA25
HP:0010514HP:0010514Hyperpituitarism0HFM1 CL E G H16404520193OMIM:615724Premature ovarian failure 96
HP:0010514HP:0010514Hyperpituitarism0HPGD CL E G H32485154ORPHA:2796Pachydermoperiostosis55
HP:0010514HP:0010514Hyperpituitarism0HSD17B4 CL E G H32955213OMIM:233400Perrault syndrome 198
HP:0010514HP:0010514Hyperpituitarism0HSD3B2 CL E G H32845218ORPHA:90791Congenital adrenal hyperplasia due to 3-beta-hydroxysteroid dehydrogenase deficiency34
HP:0010514HP:0010514Hyperpituitarism0IGF1 CL E G H34795464OMIM:608747Insulin-Like growth factor I deficiency91
HP:0010514HP:0010514Hyperpituitarism0KCNJ11 CL E G H37676257ORPHA:79644Autosomal recessive hyperinsulinism due to Kir6.2 deficiency127
HP:0010514HP:0010514Hyperpituitarism0KISS1R CL E G H846344510OMIM:176400Precocious puberty, central14
HP:0010514HP:0010514Hyperpituitarism0KLHL10 CL E G H31771918829ORPHA:399805Male infertility with azoospermia or oligozoospermia due to single gene mutation3
HP:0010514HP:0010514Hyperpituitarism0LARS2 CL E G H2339517095OMIM:615300Perrault syndrome 454
HP:0010514HP:0010514Hyperpituitarism0LHB CL E G H39726584OMIM:228300Hypogonadotropic hypogonadism 23 without anosmia9
HP:0010514HP:0010514Hyperpituitarism0LHCGR CL E G H39736585OMIM:238320Hypergonadotropic hypogonadism67
HP:0010514HP:0010514Hyperpituitarism0MAP3K1 CL E G H42146848ORPHA:25151046,XY partial gonadal dysgenesis13
HP:0010514HP:0010514Hyperpituitarism0MCM4 CL E G H41736947OMIM:609981Immunodeficiency 5469
HP:0010514HP:0010514Hyperpituitarism0MCM8 CL E G H8451516147OMIM:612885Premature ovarian failure 104
HP:0010514HP:0010514Hyperpituitarism0MCM9 CL E G H25439421484OMIM:616185Ovarian dysgenesis 44
HP:0010514HP:0010514Hyperpituitarism0MEIOB CL E G H25452828569ORPHA:399805Male infertility with azoospermia or oligozoospermia due to single gene mutation
HP:0010514HP:0010514Hyperpituitarism0MEN1 CL E G H42217010OMIM:131100Multiple endocrine neoplasia 1462
HP:0010514HP:0010514Hyperpituitarism0MEN1 CL E G H42217010ORPHA:652Multiple endocrine neoplasia type 1462
HP:0010514HP:0010514Hyperpituitarism0MEN1 CL E G H42217010ORPHA:99725Pituitary gigantism462
HP:0010514HP:0010514Hyperpituitarism0MEN1 CL E G H42217010ORPHA:2965Prolactinoma462
HP:0010514HP:0010514Hyperpituitarism0MRPS22 CL E G H5694514508ORPHA:24346,XX gonadal dysgenesis25
HP:0010514HP:0010514Hyperpituitarism0MSH4 CL E G H44387327OMIM:619938
HP:0010514HP:0010514Hyperpituitarism0MSH5 CL E G H44397328OMIM:617442Premature ovarian failure 135
HP:0010514HP:0010514Hyperpituitarism0MSTO1 CL E G H5515429678ORPHA:502423Mitochondrial myopathy-cerebellar ataxia-pigmentary retinopathy syndrome
HP:0010514HP:0010514Hyperpituitarism0MSTO1 CL E G H5515429678OMIM:617675Myopathy, mitochondrial, and ataxia
HP:0010514HP:0010514Hyperpituitarism0NANOS1 CL E G H34071923044ORPHA:399805Male infertility with azoospermia or oligozoospermia due to single gene mutation4
HP:0010514HP:0010514Hyperpituitarism0NANOS1 CL E G H34071923044ORPHA:399808Male infertility with teratozoospermia due to single gene mutation4
HP:0010514HP:0010514Hyperpituitarism0NF2 CL E G H47717773ORPHA:2495Meningioma220
HP:0010514HP:0010514Hyperpituitarism0NR0B1 CL E G H1907960ORPHA:25151046,XY partial gonadal dysgenesis48
HP:0010514HP:0010514Hyperpituitarism0NR5A1 CL E G H25167983ORPHA:24346,XX gonadal dysgenesis38
HP:0010514HP:0010514Hyperpituitarism0NR5A1 CL E G H25167983ORPHA:25151046,XY partial gonadal dysgenesis38
HP:0010514HP:0010514Hyperpituitarism0NR5A1 CL E G H25167983OMIM:61296546XY sex reversal 338
HP:0010514HP:0010514Hyperpituitarism0NR5A1 CL E G H25167983ORPHA:399805Male infertility with azoospermia or oligozoospermia due to single gene mutation38
HP:0010514HP:0010514Hyperpituitarism0NR5A1 CL E G H25167983OMIM:612964PREMATURE OVARIAN FAILURE 7; POF738
HP:0010514HP:0010514Hyperpituitarism0NSMCE2 CL E G H28605326513OMIM:617253Seckel syndrome 102
HP:0010514HP:0010514Hyperpituitarism0NUP107 CL E G H5712229914ORPHA:24346,XX gonadal dysgenesis5
HP:0010514HP:0010514Hyperpituitarism0PDE11A CL E G H509408773ORPHA:1359Carney complex13
HP:0010514HP:0010514Hyperpituitarism0PDGFB CL E G H51558800ORPHA:2495Meningioma9
HP:0010514HP:0010514Hyperpituitarism0PIK3CA CL E G H52908975ORPHA:2495Meningioma162
HP:0010514HP:0010514Hyperpituitarism0PMM2 CL E G H53739115ORPHA:79318PMM2-CDG150
HP:0010514HP:0010514Hyperpituitarism0PNLDC1 CL E G H15419721185ORPHA:399805Male infertility with azoospermia or oligozoospermia due to single gene mutation
HP:0010514HP:0010514Hyperpituitarism0POLA1 CL E G H54229173ORPHA:163976X-linked intellectual disability, Van Esch type2
HP:0010514HP:0010514Hyperpituitarism0POLR3A CL E G H1112830074ORPHA:3455Wiedemann-Rautenstrauch syndrome138
HP:0010514HP:0010514Hyperpituitarism0POLR3H CL E G H17156830349ORPHA:24346,XX gonadal dysgenesis
HP:0010514HP:0010514Hyperpituitarism0POR CL E G H54479208ORPHA:95699Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency76
HP:0010514HP:0010514Hyperpituitarism0PPP2R3C CL E G H5501217485OMIM:618419Gonadal dysgenesis, dysmorphic facies, retinal dystrophy, and myopathy
HP:0010514HP:0010514Hyperpituitarism0PRKAR1A CL E G H55739388ORPHA:1359Carney complex134
HP:0010514HP:0010514Hyperpituitarism0PRKAR1A CL E G H55739388OMIM:160980Carney complex, type 1134
HP:0010514HP:0010514Hyperpituitarism0PRLR CL E G H56189446OMIM:615555HYPERPROLACTINEMIA2
HP:0010514HP:0010514Hyperpituitarism0PSMC3IP CL E G H2989317928ORPHA:24346,XX gonadal dysgenesis2
HP:0010514HP:0010514Hyperpituitarism0PSMC3IP CL E G H2989317928OMIM:614324Ovarian dysgenesis 32
HP:0010514HP:0010514Hyperpituitarism0SHOC1 CL E G H15840126535OMIM:619949
HP:0010514HP:0010514Hyperpituitarism0SLCO2A1 CL E G H657810955ORPHA:2796Pachydermoperiostosis13
HP:0010514HP:0010514Hyperpituitarism0SMARCB1 CL E G H659811103ORPHA:2495Meningioma87
HP:0010514HP:0010514Hyperpituitarism0SMARCE1 CL E G H660511109ORPHA:2495Meningioma47
HP:0010514HP:0010514Hyperpituitarism0SMO CL E G H660811119ORPHA:2495Meningioma22
HP:0010514HP:0010514Hyperpituitarism0SOHLH1 CL E G H40238127845ORPHA:399805Male infertility with azoospermia or oligozoospermia due to single gene mutation3
HP:0010514HP:0010514Hyperpituitarism0SOX9 CL E G H666211204ORPHA:25151046,XY partial gonadal dysgenesis109
HP:0010514HP:0010514Hyperpituitarism0SPIDR CL E G H2351428971ORPHA:24346,XX gonadal dysgenesis2
HP:0010514HP:0010514Hyperpituitarism0SPIDR CL E G H2351428971OMIM:619665OVARIAN DYSGENESIS 9; ODG92
HP:0010514HP:0010514Hyperpituitarism0SRY CL E G H673611311ORPHA:177245,X/46,XY mixed gonadal dysgenesis23
HP:0010514HP:0010514Hyperpituitarism0SRY CL E G H673611311ORPHA:25151046,XY partial gonadal dysgenesis23
HP:0010514HP:0010514Hyperpituitarism0SRY CL E G H673611311OMIM:40004546XX sex reversal 123
HP:0010514HP:0010514Hyperpituitarism0SRY CL E G H673611311OMIM:40004446XY sex reversal 123
HP:0010514HP:0010514Hyperpituitarism0STAG3 CL E G H1073411356OMIM:615723Premature ovarian failure 84
HP:0010514HP:0010514Hyperpituitarism0SUFU CL E G H5168416466ORPHA:2495Meningioma124
HP:0010514HP:0010514Hyperpituitarism0SYCE1 CL E G H9342628852ORPHA:399805Male infertility with azoospermia or oligozoospermia due to single gene mutation4
HP:0010514HP:0010514Hyperpituitarism0SYCP3 CL E G H5051118130ORPHA:399805Male infertility with azoospermia or oligozoospermia due to single gene mutation12
HP:0010514HP:0010514Hyperpituitarism0TAF4B CL E G H687511538ORPHA:399805Male infertility with azoospermia or oligozoospermia due to single gene mutation1
HP:0010514HP:0010514Hyperpituitarism0TDRD9 CL E G H12240220122ORPHA:399805Male infertility with azoospermia or oligozoospermia due to single gene mutation
HP:0010514HP:0010514Hyperpituitarism0TERT CL E G H701511730ORPHA:2495Meningioma238
HP:0010514HP:0010514Hyperpituitarism0TEX11 CL E G H5615911733ORPHA:399805Male infertility with azoospermia or oligozoospermia due to single gene mutation5
HP:0010514HP:0010514Hyperpituitarism0TEX14 CL E G H5615511737ORPHA:399805Male infertility with azoospermia or oligozoospermia due to single gene mutation1
HP:0010514HP:0010514Hyperpituitarism0TEX15 CL E G H5615411738ORPHA:399805Male infertility with azoospermia or oligozoospermia due to single gene mutation1
HP:0010514HP:0010514Hyperpituitarism0TRAF7 CL E G H8423120456ORPHA:2495Meningioma
HP:0010514HP:0010514Hyperpituitarism0TRHR CL E G H720112299ORPHA:99832Resistance to thyrotropin-releasing hormone syndrome2
HP:0010514HP:0010514Hyperpituitarism0TSHB CL E G H725212372ORPHA:90674Isolated thyroid-stimulating hormone deficiency9
HP:0010514HP:0010514Hyperpituitarism0VAMP7 CL E G H684511486ORPHA:25151046,XY partial gonadal dysgenesis2
HP:0010514HP:0010514Hyperpituitarism0WT1 CL E G H749012796ORPHA:25151046,XY partial gonadal dysgenesis177
HP:0010514HP:0010514Hyperpituitarism0WT1 CL E G H749012796ORPHA:347Frasier syndrome177
HP:0010514HP:0010514Hyperpituitarism0WWOX CL E G H5174112799ORPHA:25151046,XY partial gonadal dysgenesis149
HP:0010514HP:0010514Hyperpituitarism0XRCC2 CL E G H751612829ORPHA:399805Male infertility with azoospermia or oligozoospermia due to single gene mutation125
HP:0010514HP:0010514Hyperpituitarism0XRCC2 CL E G H751612829OMIM:619146PREMATURE OVARIAN FAILURE 17; POF17125
HP:0010514HP:0010514Hyperpituitarism0ZFPM2 CL E G H2341416700ORPHA:25151046,XY partial gonadal dysgenesis31
HP:0010514HP:0010514Hyperpituitarism0ZMYND15 CL E G H8422520997ORPHA:399805Male infertility with azoospermia or oligozoospermia due to single gene mutation1
HP:0010514HP:0010514Hyperpituitarism0ZMYND15 CL E G H8422520997OMIM:615842Spermatogenic failure 141
HP:0010514HP:0010514Hyperpituitarism0ZSWIM7 CL E G H12515026993ORPHA:24346,XX gonadal dysgenesis
HP:0010514HP:0010514Hyperpituitarism0ZSWIM7 CL E G H12515026993OMIM:619834OVARIAN DYSGENESIS 10; ODG10
HP:0010514HP:0011749Adrenocorticotropic hormone excess1ABCD1 CL E G H21561ORPHA:139399AdrenomyeloneuropathyHP:0040282 - Frequent135
HP:0010514HP:0000845Elevated circulating growth hormone concentration1AIP CL E G H9049358ORPHA:963AcromegalyHP:0040281 - Very frequent95
HP:0010514HP:0000870Increased circulating prolactin concentration1AIP CL E G H9049358OMIM:102200Pituitary adenoma, growth hormone-secreting, 1.95
HP:0010514HP:0000845Elevated circulating growth hormone concentration1AIP CL E G H9049358OMIM:102200Pituitary adenoma, growth hormone-secreting, 1.95
HP:0010514HP:0000870Increased circulating prolactin concentration1AIP CL E G H9049358ORPHA:99725Pituitary gigantismHP:0040282 - Frequent95
HP:0010514HP:0000845Elevated circulating growth hormone concentration1AIP CL E G H9049358ORPHA:99725Pituitary gigantismHP:0040281 - Very frequent95
HP:0010514HP:0000845Elevated circulating growth hormone concentration1AIP CL E G H9049358ORPHA:2965ProlactinomaHP:0040283 - Occasional95
HP:0010514HP:0000870Increased circulating prolactin concentration1AKT1 CL E G H207391ORPHA:2495MeningiomaHP:0040282 - Frequent54
HP:0010514HP:0000837Increased circulating gonadotropin level1AR CL E G H367644OMIM:300068Androgen insensitivity syndrome125
HP:0010514HP:0000837Increased circulating gonadotropin level1AR CL E G H367644ORPHA:99429Complete androgen insensitivity syndrome125
HP:0010514HP:0000837Increased circulating gonadotropin level1AR CL E G H367644ORPHA:90797Partial androgen insensitivity syndrome125
HP:0010514HP:0000870Increased circulating prolactin concentration1BAP1 CL E G H8314950ORPHA:2495MeningiomaHP:0040282 - Frequent184
HP:0010514HP:0000837Increased circulating gonadotropin level1BMP15 CL E G H92101068ORPHA:24346,XX gonadal dysgenesisHP:0040281 - Very frequent16
HP:0010514HP:0000837Increased circulating gonadotropin level1BMPR1B CL E G H6581077OMIM:609441Acromesomelic dysplasia, Demirhan type90
HP:0010514HP:0000837Increased circulating gonadotropin level1BNC1 CL E G H6461081ORPHA:24346,XX gonadal dysgenesisHP:0040281 - Very frequent
HP:0010514HP:0000837Increased circulating gonadotropin level1BNC1 CL E G H6461081OMIM:618723PREMATURE OVARIAN FAILURE 16; POF16
HP:0010514HP:0000870Increased circulating prolactin concentration1BRAF CL E G H6731097ORPHA:54595CraniopharyngiomaHP:0040282 - Frequent276
HP:0010514HP:0000837Increased circulating gonadotropin level1C14ORF39 CL E G H31776119849ORPHA:399805Male infertility with azoospermia or oligozoospermia due to single gene mutationHP:0040281 - Very frequent
HP:0010514HP:0000837Increased circulating gonadotropin level1C14ORF39 CL E G H31776119849OMIM:619203PREMATURE OVARIAN FAILURE 18; POF18
HP:0010514HP:0000837Increased circulating gonadotropin level1CBX2 CL E G H847331552OMIM:61308046XY sex reversal 53
HP:0010514HP:0000837Increased circulating gonadotropin level1CCDC34 CL E G H9105725079ORPHA:399805Male infertility with azoospermia or oligozoospermia due to single gene mutationHP:0040281 - Very frequent
HP:0010514HP:0000845Elevated circulating growth hormone concentration1CDH23 CL E G H6407213733ORPHA:2965ProlactinomaHP:0040283 - Occasional636
HP:0010514HP:0000845Elevated circulating growth hormone concentration1CDH23 CL E G H6407213733ORPHA:91347TSH-secreting pituitary adenomaHP:0040283 - Occasional636
HP:0010514HP:0000870Increased circulating prolactin concentration1CDH23 CL E G H6407213733ORPHA:91347TSH-secreting pituitary adenomaHP:0040283 - Occasional636
HP:0010514HP:0000837Increased circulating gonadotropin level1CDH23 CL E G H6407213733ORPHA:91347TSH-secreting pituitary adenomaHP:0040283 - Occasional636
HP:0010514HP:0000845Elevated circulating growth hormone concentration1CDKN1A CL E G H10261784ORPHA:652Multiple endocrine neoplasia type 1HP:0040283 - Occasional2
HP:0010514HP:0000845Elevated circulating growth hormone concentration1CDKN1B CL E G H10271785ORPHA:652Multiple endocrine neoplasia type 1HP:0040283 - Occasional102
HP:0010514HP:0000845Elevated circulating growth hormone concentration1CDKN1B CL E G H10271785ORPHA:276152Multiple endocrine neoplasia type 4HP:0040282 - Frequent102
HP:0010514HP:0000845Elevated circulating growth hormone concentration1CDKN1B CL E G H10271785OMIM:610755Multiple endocrine neoplasia, type IV.102
HP:0010514HP:0000845Elevated circulating growth hormone concentration1CDKN2B CL E G H10301788ORPHA:652Multiple endocrine neoplasia type 1HP:0040283 - Occasional1
HP:0010514HP:0000845Elevated circulating growth hormone concentration1CDKN2C CL E G H10311789ORPHA:652Multiple endocrine neoplasia type 1HP:0040283 - Occasional
HP:0010514HP:0000837Increased circulating gonadotropin level1CFTR CL E G H10801884ORPHA:399805Male infertility with azoospermia or oligozoospermia due to single gene mutationHP:0040281 - Very frequent1371
HP:0010514HP:0000837Increased circulating gonadotropin level1CNBP CL E G H755513164OMIM:602668Dystrophia myotonica 21
HP:0010514HP:0000870Increased circulating prolactin concentration1CTNNB1 CL E G H14992514ORPHA:54595CraniopharyngiomaHP:0040282 - Frequent88
HP:0010514HP:0000837Increased circulating gonadotropin level1CYB5A CL E G H15282570ORPHA:9079646,XY disorder of sex development due to isolated 17,20-lyase deficiency2
HP:0010514HP:0000837Increased circulating gonadotropin level1CYP11A1 CL E G H15832590ORPHA:16855846,XY disorder of sex development-adrenal insufficiency due to CYP11A1 deficiency31
HP:0010514HP:0011749Adrenocorticotropic hormone excess1CYP11A1 CL E G H15832590ORPHA:16855846,XY disorder of sex development-adrenal insufficiency due to CYP11A1 deficiencyHP:0040281 - Very frequent31
HP:0010514HP:0011749Adrenocorticotropic hormone excess1CYP11A1 CL E G H15832590OMIM:613743Adrenal insufficiency, congenital, with 46XY sex reversal, partial or complete.31
HP:0010514HP:0000837Increased circulating gonadotropin level1CYP11A1 CL E G H15832590ORPHA:289548Inherited isolated adrenal insufficiency due to partial CYP11A1 deficiency31
HP:0010514HP:0011749Adrenocorticotropic hormone excess1CYP11A1 CL E G H15832590ORPHA:289548Inherited isolated adrenal insufficiency due to partial CYP11A1 deficiencyHP:0040281 - Very frequent31
HP:0010514HP:0000837Increased circulating gonadotropin level1CYP17A1 CL E G H15862593ORPHA:9079646,XY disorder of sex development due to isolated 17,20-lyase deficiency53
HP:0010514HP:0000837Increased circulating gonadotropin level1CYP17A1 CL E G H15862593ORPHA:90793Congenital adrenal hyperplasia due to 17-alpha-hydroxylase deficiencyHP:0040281 - Very frequent53
HP:0010514HP:0011749Adrenocorticotropic hormone excess1CYP17A1 CL E G H15862593ORPHA:90793Congenital adrenal hyperplasia due to 17-alpha-hydroxylase deficiencyHP:0040282 - Frequent53
HP:0010514HP:0000837Increased circulating gonadotropin level1DHH CL E G H508462865ORPHA:16856346,XY gonadal dysgenesis-motor and sensory neuropathy syndromeHP:0040281 - Very frequent21
HP:0010514HP:0000837Increased circulating gonadotropin level1DHX37 CL E G H5764717210OMIM:27325046, XY sex reversal 112
HP:0010514HP:0000837Increased circulating gonadotropin level1DHX37 CL E G H5764717210ORPHA:25151046,XY partial gonadal dysgenesisHP:0040281 - Very frequent2
HP:0010514HP:0000837Increased circulating gonadotropin level1DIAPH2 CL E G H17302877OMIM:300511Premature ovarian failure 2A6
HP:0010514HP:0000837Increased circulating gonadotropin level1DMRT3 CL E G H5852413909ORPHA:25151046,XY partial gonadal dysgenesisHP:0040281 - Very frequent1
HP:0010514HP:0000837Increased circulating gonadotropin level1ERCC6 CL E G H20743438OMIM:616946PREMATURE OVARIAN FAILURE 11; POF11199
HP:0010514HP:0000837Increased circulating gonadotropin level1ESR1 CL E G H20993467ORPHA:785Estrogen resistance syndromeHP:0040281 - Very frequent13
HP:0010514HP:0000837Increased circulating gonadotropin level1ESR2 CL E G H21003468OMIM:618187Ovarian dysgenesis 8
HP:0010514HP:0000837Increased circulating gonadotropin level1FANCM CL E G H5769723168ORPHA:399805Male infertility with azoospermia or oligozoospermia due to single gene mutationHP:0040281 - Very frequent107
HP:0010514HP:0000837Increased circulating gonadotropin level1FANCM CL E G H5769723168OMIM:618086Spermatogenic failure 28107
HP:0010514HP:0000837Increased circulating gonadotropin level1FGD1 CL E G H22453663OMIM:305400Aarskog-Scott syndrome62
HP:0010514HP:0000837Increased circulating gonadotropin level1FIGLA CL E G H34401824669OMIM:612310PREMATURE OVARIAN FAILURE 6; POF617
HP:0010514HP:0000837Increased circulating gonadotropin level1FKBP6 CL E G H84683722OMIM:620103
HP:0010514HP:0000837Increased circulating gonadotropin level1FMR1 CL E G H23323775OMIM:311360Premature ovarian failure 1.30
HP:0010514HP:0000837Increased circulating gonadotropin level1FOXL2 CL E G H6681092OMIM:110100Blepharophimosis, epicanthus inversus, and ptosis.92
HP:0010514HP:0000837Increased circulating gonadotropin level1FOXL2 CL E G H6681092ORPHA:572333Blepharophimosis-ptosis-epicanthus inversus syndrome plus92
HP:0010514HP:0000837Increased circulating gonadotropin level1FSHB CL E G H24883964OMIM:229070Hypogonadotropic hypogonadism 24 without anosmia23
HP:0010514HP:0000837Increased circulating gonadotropin level1FSHR CL E G H24923969ORPHA:24346,XX gonadal dysgenesisHP:0040281 - Very frequent50
HP:0010514HP:0000837Increased circulating gonadotropin level1FSHR CL E G H24923969OMIM:233300Ovarian dysgenesis 1.50
HP:0010514HP:0000837Increased circulating gonadotropin level1FSHR CL E G H24923969ORPHA:64739Ovarian hyperstimulation syndromeHP:0040281 - Very frequent50
HP:0010514HP:0000837Increased circulating gonadotropin level1GATA4 CL E G H26264173ORPHA:25151046,XY partial gonadal dysgenesisHP:0040281 - Very frequent87
HP:0010514HP:0000837Increased circulating gonadotropin level1GCNA CL E G H9395315805OMIM:301077SPERMATOGENIC FAILURE, X-LINKED, 4; SPGFX4
HP:0010514HP:0000837Increased circulating gonadotropin level1GDF9 CL E G H26614224OMIM:618014Premature ovarian failure 142
HP:0010514HP:0000870Increased circulating prolactin concentration1GNAS CL E G H27784392ORPHA:562McCune-Albright syndromeHP:0040283 - Occasional101
HP:0010514HP:0000845Elevated circulating growth hormone concentration1GNAS CL E G H27784392ORPHA:562McCune-Albright syndromeHP:0040283 - Occasional101
HP:0010514HP:0000870Increased circulating prolactin concentration1GNAS CL E G H27784392OMIM:174800McCune-Albright syndrome, somatic, mosaic.101
HP:0010514HP:0000845Elevated circulating growth hormone concentration1GNAS CL E G H27784392OMIM:174800McCune-Albright syndrome, somatic, mosaic.101
HP:0010514HP:0000845Elevated circulating growth hormone concentration1GPR101 CL E G H8355014963ORPHA:963AcromegalyHP:0040281 - Very frequent5
HP:0010514HP:0000870Increased circulating prolactin concentration1GPR101 CL E G H8355014963OMIM:300942Chromosome Xq26.3 duplication syndrome5
HP:0010514HP:0000845Elevated circulating growth hormone concentration1GPR101 CL E G H8355014963OMIM:300942Chromosome Xq26.3 duplication syndrome5
HP:0010514HP:0000845Elevated circulating growth hormone concentration1GPR101 CL E G H8355014963OMIM:300943PITUITARY ADENOMA 2, GROWTH HORMONE-SECRETING; PITA25
HP:0010514HP:0000837Increased circulating gonadotropin level1HFM1 CL E G H16404520193OMIM:615724Premature ovarian failure 9.6
HP:0010514HP:0000845Elevated circulating growth hormone concentration1HPGD CL E G H32485154ORPHA:2796PachydermoperiostosisHP:0040283 - Occasional55
HP:0010514HP:0000837Increased circulating gonadotropin level1HSD17B4 CL E G H32955213OMIM:233400Perrault syndrome 1.98
HP:0010514HP:0011749Adrenocorticotropic hormone excess1HSD3B2 CL E G H32845218ORPHA:90791Congenital adrenal hyperplasia due to 3-beta-hydroxysteroid dehydrogenase deficiencyHP:0040282 - Frequent34
HP:0010514HP:0000845Elevated circulating growth hormone concentration1IGF1 CL E G H34795464OMIM:608747Insulin-Like growth factor I deficiency91
HP:0010514HP:0000845Elevated circulating growth hormone concentration1KCNJ11 CL E G H37676257ORPHA:79644Autosomal recessive hyperinsulinism due to Kir6.2 deficiency127
HP:0010514HP:0000837Increased circulating gonadotropin level1KISS1R CL E G H846344510OMIM:176400Precocious puberty, central14
HP:0010514HP:0000837Increased circulating gonadotropin level1KLHL10 CL E G H31771918829ORPHA:399805Male infertility with azoospermia or oligozoospermia due to single gene mutationHP:0040281 - Very frequent3
HP:0010514HP:0000837Increased circulating gonadotropin level1LARS2 CL E G H2339517095OMIM:615300Perrault syndrome 454
HP:0010514HP:0000837Increased circulating gonadotropin level1LHB CL E G H39726584OMIM:228300Hypogonadotropic hypogonadism 23 without anosmia9
HP:0010514HP:0000837Increased circulating gonadotropin level1LHCGR CL E G H39736585OMIM:238320Hypergonadotropic hypogonadism.67
HP:0010514HP:0000837Increased circulating gonadotropin level1MAP3K1 CL E G H42146848ORPHA:25151046,XY partial gonadal dysgenesisHP:0040281 - Very frequent13
HP:0010514HP:0011749Adrenocorticotropic hormone excess1MCM4 CL E G H41736947OMIM:609981Immunodeficiency 5469
HP:0010514HP:0000837Increased circulating gonadotropin level1MCM8 CL E G H8451516147OMIM:612885Premature ovarian failure 104
HP:0010514HP:0000837Increased circulating gonadotropin level1MCM9 CL E G H25439421484OMIM:616185Ovarian dysgenesis 44
HP:0010514HP:0000837Increased circulating gonadotropin level1MEIOB CL E G H25452828569ORPHA:399805Male infertility with azoospermia or oligozoospermia due to single gene mutationHP:0040281 - Very frequent
HP:0010514HP:0000845Elevated circulating growth hormone concentration1MEN1 CL E G H42217010OMIM:131100Multiple endocrine neoplasia 1.462
HP:0010514HP:0000870Increased circulating prolactin concentration1MEN1 CL E G H42217010OMIM:131100Multiple endocrine neoplasia 1462
HP:0010514HP:0000845Elevated circulating growth hormone concentration1MEN1 CL E G H42217010ORPHA:652Multiple endocrine neoplasia type 1HP:0040283 - Occasional462
HP:0010514HP:0000870Increased circulating prolactin concentration1MEN1 CL E G H42217010ORPHA:99725Pituitary gigantismHP:0040282 - Frequent462
HP:0010514HP:0000845Elevated circulating growth hormone concentration1MEN1 CL E G H42217010ORPHA:99725Pituitary gigantismHP:0040281 - Very frequent462
HP:0010514HP:0000845Elevated circulating growth hormone concentration1MEN1 CL E G H42217010ORPHA:2965ProlactinomaHP:0040283 - Occasional462
HP:0010514HP:0000837Increased circulating gonadotropin level1MRPS22 CL E G H5694514508ORPHA:24346,XX gonadal dysgenesisHP:0040281 - Very frequent25
HP:0010514HP:0000837Increased circulating gonadotropin level1MSH4 CL E G H44387327OMIM:619938
HP:0010514HP:0000837Increased circulating gonadotropin level1MSH5 CL E G H44397328OMIM:617442Premature ovarian failure 135
HP:0010514HP:0000870Increased circulating prolactin concentration1MSTO1 CL E G H5515429678ORPHA:502423Mitochondrial myopathy-cerebellar ataxia-pigmentary retinopathy syndromeHP:0040282 - Frequent
HP:0010514HP:0000870Increased circulating prolactin concentration1MSTO1 CL E G H5515429678OMIM:617675Myopathy, mitochondrial, and ataxia.
HP:0010514HP:0000837Increased circulating gonadotropin level1NANOS1 CL E G H34071923044ORPHA:399805Male infertility with azoospermia or oligozoospermia due to single gene mutationHP:0040281 - Very frequent4
HP:0010514HP:0000837Increased circulating gonadotropin level1NANOS1 CL E G H34071923044ORPHA:399808Male infertility with teratozoospermia due to single gene mutationHP:0040281 - Very frequent4
HP:0010514HP:0000870Increased circulating prolactin concentration1NF2 CL E G H47717773ORPHA:2495MeningiomaHP:0040282 - Frequent220
HP:0010514HP:0000837Increased circulating gonadotropin level1NR0B1 CL E G H1907960ORPHA:25151046,XY partial gonadal dysgenesisHP:0040281 - Very frequent48
HP:0010514HP:0000837Increased circulating gonadotropin level1NR5A1 CL E G H25167983ORPHA:24346,XX gonadal dysgenesisHP:0040281 - Very frequent38
HP:0010514HP:0000837Increased circulating gonadotropin level1NR5A1 CL E G H25167983ORPHA:25151046,XY partial gonadal dysgenesisHP:0040281 - Very frequent38
HP:0010514HP:0000837Increased circulating gonadotropin level1NR5A1 CL E G H25167983OMIM:61296546XY sex reversal 338
HP:0010514HP:0000837Increased circulating gonadotropin level1NR5A1 CL E G H25167983ORPHA:399805Male infertility with azoospermia or oligozoospermia due to single gene mutationHP:0040281 - Very frequent38
HP:0010514HP:0000837Increased circulating gonadotropin level1NR5A1 CL E G H25167983OMIM:612964PREMATURE OVARIAN FAILURE 7; POF738
HP:0010514HP:0000837Increased circulating gonadotropin level1NSMCE2 CL E G H28605326513OMIM:617253Seckel syndrome 102
HP:0010514HP:0000837Increased circulating gonadotropin level1NUP107 CL E G H5712229914ORPHA:24346,XX gonadal dysgenesisHP:0040281 - Very frequent5
HP:0010514HP:0000845Elevated circulating growth hormone concentration1PDE11A CL E G H509408773ORPHA:1359Carney complexHP:0040282 - Frequent13
HP:0010514HP:0000870Increased circulating prolactin concentration1PDE11A CL E G H509408773ORPHA:1359Carney complex13
HP:0010514HP:0000870Increased circulating prolactin concentration1PDGFB CL E G H51558800ORPHA:2495MeningiomaHP:0040282 - Frequent9
HP:0010514HP:0000870Increased circulating prolactin concentration1PIK3CA CL E G H52908975ORPHA:2495MeningiomaHP:0040282 - Frequent162
HP:0010514HP:0000870Increased circulating prolactin concentration1PMM2 CL E G H53739115ORPHA:79318PMM2-CDGHP:0040283 - Occasional150
HP:0010514HP:0000845Elevated circulating growth hormone concentration1PMM2 CL E G H53739115ORPHA:79318PMM2-CDGHP:0040283 - Occasional150
HP:0010514HP:0000837Increased circulating gonadotropin level1PNLDC1 CL E G H15419721185ORPHA:399805Male infertility with azoospermia or oligozoospermia due to single gene mutationHP:0040281 - Very frequent
HP:0010514HP:0000837Increased circulating gonadotropin level1POLA1 CL E G H54229173ORPHA:163976X-linked intellectual disability, Van Esch typeHP:0040282 - Frequent2
HP:0010514HP:0000870Increased circulating prolactin concentration1POLR3A CL E G H1112830074ORPHA:3455Wiedemann-Rautenstrauch syndromeHP:0040282 - Frequent138
HP:0010514HP:0000837Increased circulating gonadotropin level1POLR3H CL E G H17156830349ORPHA:24346,XX gonadal dysgenesisHP:0040281 - Very frequent
HP:0010514HP:0000837Increased circulating gonadotropin level1POR CL E G H54479208ORPHA:95699Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency76
HP:0010514HP:0000837Increased circulating gonadotropin level1PPP2R3C CL E G H5501217485OMIM:618419Gonadal dysgenesis, dysmorphic facies, retinal dystrophy, and myopathy
HP:0010514HP:0000870Increased circulating prolactin concentration1PRKAR1A CL E G H55739388ORPHA:1359Carney complex134
HP:0010514HP:0000845Elevated circulating growth hormone concentration1PRKAR1A CL E G H55739388ORPHA:1359Carney complexHP:0040282 - Frequent134
HP:0010514HP:0000845Elevated circulating growth hormone concentration1PRKAR1A CL E G H55739388OMIM:160980Carney complex, type 1.134
HP:0010514HP:0000870Increased circulating prolactin concentration1PRLR CL E G H56189446OMIM:615555HYPERPROLACTINEMIA.2
HP:0010514HP:0000837Increased circulating gonadotropin level1PSMC3IP CL E G H2989317928ORPHA:24346,XX gonadal dysgenesisHP:0040281 - Very frequent2
HP:0010514HP:0000837Increased circulating gonadotropin level1PSMC3IP CL E G H2989317928OMIM:614324Ovarian dysgenesis 32
HP:0010514HP:0000837Increased circulating gonadotropin level1SHOC1 CL E G H15840126535OMIM:619949
HP:0010514HP:0000845Elevated circulating growth hormone concentration1SLCO2A1 CL E G H657810955ORPHA:2796PachydermoperiostosisHP:0040283 - Occasional13
HP:0010514HP:0000870Increased circulating prolactin concentration1SMARCB1 CL E G H659811103ORPHA:2495MeningiomaHP:0040282 - Frequent87
HP:0010514HP:0000870Increased circulating prolactin concentration1SMARCE1 CL E G H660511109ORPHA:2495MeningiomaHP:0040282 - Frequent47
HP:0010514HP:0000870Increased circulating prolactin concentration1SMO CL E G H660811119ORPHA:2495MeningiomaHP:0040282 - Frequent22
HP:0010514HP:0000837Increased circulating gonadotropin level1SOHLH1 CL E G H40238127845ORPHA:399805Male infertility with azoospermia or oligozoospermia due to single gene mutationHP:0040281 - Very frequent3
HP:0010514HP:0000837Increased circulating gonadotropin level1SOX9 CL E G H666211204ORPHA:25151046,XY partial gonadal dysgenesisHP:0040281 - Very frequent109
HP:0010514HP:0000837Increased circulating gonadotropin level1SPIDR CL E G H2351428971ORPHA:24346,XX gonadal dysgenesisHP:0040281 - Very frequent2
HP:0010514HP:0000837Increased circulating gonadotropin level1SPIDR CL E G H2351428971OMIM:619665OVARIAN DYSGENESIS 9; ODG92
HP:0010514HP:0000837Increased circulating gonadotropin level1SRY CL E G H673611311ORPHA:177245,X/46,XY mixed gonadal dysgenesisHP:0040282 - Frequent23
HP:0010514HP:0000837Increased circulating gonadotropin level1SRY CL E G H673611311ORPHA:25151046,XY partial gonadal dysgenesisHP:0040281 - Very frequent23
HP:0010514HP:0000837Increased circulating gonadotropin level1SRY CL E G H673611311OMIM:40004546XX sex reversal 123
HP:0010514HP:0000837Increased circulating gonadotropin level1SRY CL E G H673611311OMIM:40004446XY sex reversal 123
HP:0010514HP:0000837Increased circulating gonadotropin level1STAG3 CL E G H1073411356OMIM:615723Premature ovarian failure 8.4
HP:0010514HP:0000870Increased circulating prolactin concentration1SUFU CL E G H5168416466ORPHA:2495MeningiomaHP:0040282 - Frequent124
HP:0010514HP:0000837Increased circulating gonadotropin level1SYCE1 CL E G H9342628852ORPHA:399805Male infertility with azoospermia or oligozoospermia due to single gene mutationHP:0040281 - Very frequent4
HP:0010514HP:0000837Increased circulating gonadotropin level1SYCP3 CL E G H5051118130ORPHA:399805Male infertility with azoospermia or oligozoospermia due to single gene mutationHP:0040281 - Very frequent12
HP:0010514HP:0000837Increased circulating gonadotropin level1TAF4B CL E G H687511538ORPHA:399805Male infertility with azoospermia or oligozoospermia due to single gene mutationHP:0040281 - Very frequent1
HP:0010514HP:0000837Increased circulating gonadotropin level1TDRD9 CL E G H12240220122ORPHA:399805Male infertility with azoospermia or oligozoospermia due to single gene mutationHP:0040281 - Very frequent
HP:0010514HP:0000870Increased circulating prolactin concentration1TERT CL E G H701511730ORPHA:2495MeningiomaHP:0040282 - Frequent238
HP:0010514HP:0000837Increased circulating gonadotropin level1TEX11 CL E G H5615911733ORPHA:399805Male infertility with azoospermia or oligozoospermia due to single gene mutationHP:0040281 - Very frequent5
HP:0010514HP:0000837Increased circulating gonadotropin level1TEX14 CL E G H5615511737ORPHA:399805Male infertility with azoospermia or oligozoospermia due to single gene mutationHP:0040281 - Very frequent1
HP:0010514HP:0000837Increased circulating gonadotropin level1TEX15 CL E G H5615411738ORPHA:399805Male infertility with azoospermia or oligozoospermia due to single gene mutationHP:0040281 - Very frequent1
HP:0010514HP:0000870Increased circulating prolactin concentration1TRAF7 CL E G H8423120456ORPHA:2495MeningiomaHP:0040282 - Frequent
HP:0010514HP:0000870Increased circulating prolactin concentration1TRHR CL E G H720112299ORPHA:99832Resistance to thyrotropin-releasing hormone syndromeHP:0040282 - Frequent2
HP:0010514HP:0000870Increased circulating prolactin concentration1TSHB CL E G H725212372ORPHA:90674Isolated thyroid-stimulating hormone deficiencyHP:0040282 - Frequent9
HP:0010514HP:0000837Increased circulating gonadotropin level1VAMP7 CL E G H684511486ORPHA:25151046,XY partial gonadal dysgenesisHP:0040281 - Very frequent2
HP:0010514HP:0000837Increased circulating gonadotropin level1WT1 CL E G H749012796ORPHA:25151046,XY partial gonadal dysgenesisHP:0040281 - Very frequent177
HP:0010514HP:0000837Increased circulating gonadotropin level1WT1 CL E G H749012796ORPHA:347Frasier syndromeHP:0040281 - Very frequent177
HP:0010514HP:0000837Increased circulating gonadotropin level1WWOX CL E G H5174112799ORPHA:25151046,XY partial gonadal dysgenesisHP:0040281 - Very frequent149
HP:0010514HP:0000837Increased circulating gonadotropin level1XRCC2 CL E G H751612829ORPHA:399805Male infertility with azoospermia or oligozoospermia due to single gene mutationHP:0040281 - Very frequent125
HP:0010514HP:0000837Increased circulating gonadotropin level1XRCC2 CL E G H751612829OMIM:619146PREMATURE OVARIAN FAILURE 17; POF17125
HP:0010514HP:0000837Increased circulating gonadotropin level1ZFPM2 CL E G H2341416700ORPHA:25151046,XY partial gonadal dysgenesisHP:0040281 - Very frequent31
HP:0010514HP:0000837Increased circulating gonadotropin level1ZMYND15 CL E G H8422520997ORPHA:399805Male infertility with azoospermia or oligozoospermia due to single gene mutationHP:0040281 - Very frequent1
HP:0010514HP:0000837Increased circulating gonadotropin level1ZMYND15 CL E G H8422520997OMIM:615842Spermatogenic failure 141
HP:0010514HP:0000837Increased circulating gonadotropin level1ZSWIM7 CL E G H12515026993ORPHA:24346,XX gonadal dysgenesisHP:0040281 - Very frequent
HP:0010514HP:0000837Increased circulating gonadotropin level1ZSWIM7 CL E G H12515026993OMIM:619834OVARIAN DYSGENESIS 10; ODG10
HP:0010514HP:0008232Elevated circulating follicle stimulating hormone level2AR CL E G H367644OMIM:300068Androgen insensitivity syndrome.125
HP:0010514HP:0011969Elevated circulating luteinizing hormone level2AR CL E G H367644OMIM:300068Androgen insensitivity syndrome.125
HP:0010514HP:0011969Elevated circulating luteinizing hormone level2AR CL E G H367644ORPHA:99429Complete androgen insensitivity syndromeHP:0040281 - Very frequent125
HP:0010514HP:0011969Elevated circulating luteinizing hormone level2AR CL E G H367644ORPHA:90797Partial androgen insensitivity syndromeHP:0040281 - Very frequent125
HP:0010514HP:0008232Elevated circulating follicle stimulating hormone level2BMPR1B CL E G H6581077OMIM:609441Acromesomelic dysplasia, Demirhan type90
HP:0010514HP:0011969Elevated circulating luteinizing hormone level2BMPR1B CL E G H6581077OMIM:609441Acromesomelic dysplasia, Demirhan type90
HP:0010514HP:0008232Elevated circulating follicle stimulating hormone level2BNC1 CL E G H6461081OMIM:618723PREMATURE OVARIAN FAILURE 16; POF16
HP:0010514HP:0008232Elevated circulating follicle stimulating hormone level2C14ORF39 CL E G H31776119849OMIM:619203PREMATURE OVARIAN FAILURE 18; POF18
HP:0010514HP:0011969Elevated circulating luteinizing hormone level2C14ORF39 CL E G H31776119849OMIM:619203PREMATURE OVARIAN FAILURE 18; POF18
HP:0010514HP:0008232Elevated circulating follicle stimulating hormone level2CBX2 CL E G H847331552OMIM:61308046XY sex reversal 5.3
HP:0010514HP:0008232Elevated circulating follicle stimulating hormone level2CNBP CL E G H755513164OMIM:602668Dystrophia myotonica 2.1
HP:0010514HP:0011969Elevated circulating luteinizing hormone level2CYB5A CL E G H15282570ORPHA:9079646,XY disorder of sex development due to isolated 17,20-lyase deficiencyHP:0040281 - Very frequent2
HP:0010514HP:0008232Elevated circulating follicle stimulating hormone level2CYB5A CL E G H15282570ORPHA:9079646,XY disorder of sex development due to isolated 17,20-lyase deficiencyHP:0040281 - Very frequent2
HP:0010514HP:0008232Elevated circulating follicle stimulating hormone level2CYP11A1 CL E G H15832590ORPHA:16855846,XY disorder of sex development-adrenal insufficiency due to CYP11A1 deficiencyHP:0040282 - Frequent31
HP:0010514HP:0011969Elevated circulating luteinizing hormone level2CYP11A1 CL E G H15832590ORPHA:16855846,XY disorder of sex development-adrenal insufficiency due to CYP11A1 deficiencyHP:0040282 - Frequent31
HP:0010514HP:0011969Elevated circulating luteinizing hormone level2CYP11A1 CL E G H15832590ORPHA:289548Inherited isolated adrenal insufficiency due to partial CYP11A1 deficiencyHP:0040282 - Frequent31
HP:0010514HP:0008232Elevated circulating follicle stimulating hormone level2CYP11A1 CL E G H15832590ORPHA:289548Inherited isolated adrenal insufficiency due to partial CYP11A1 deficiencyHP:0040282 - Frequent31
HP:0010514HP:0008232Elevated circulating follicle stimulating hormone level2CYP17A1 CL E G H15862593ORPHA:9079646,XY disorder of sex development due to isolated 17,20-lyase deficiencyHP:0040281 - Very frequent53
HP:0010514HP:0011969Elevated circulating luteinizing hormone level2CYP17A1 CL E G H15862593ORPHA:9079646,XY disorder of sex development due to isolated 17,20-lyase deficiencyHP:0040281 - Very frequent53
HP:0010514HP:0008232Elevated circulating follicle stimulating hormone level2CYP17A1 CL E G H15862593ORPHA:90793Congenital adrenal hyperplasia due to 17-alpha-hydroxylase deficiencyHP:0040282 - Frequent53
HP:0010514HP:0011969Elevated circulating luteinizing hormone level2CYP17A1 CL E G H15862593ORPHA:90793Congenital adrenal hyperplasia due to 17-alpha-hydroxylase deficiencyHP:0040282 - Frequent53
HP:0010514HP:0011969Elevated circulating luteinizing hormone level2DHX37 CL E G H5764717210OMIM:27325046, XY sex reversal 112
HP:0010514HP:0008232Elevated circulating follicle stimulating hormone level2DHX37 CL E G H5764717210OMIM:27325046, XY sex reversal 112
HP:0010514HP:0008232Elevated circulating follicle stimulating hormone level2DHX37 CL E G H5764717210ORPHA:25151046,XY partial gonadal dysgenesisHP:0040281 - Very frequent2
HP:0010514HP:0011969Elevated circulating luteinizing hormone level2DHX37 CL E G H5764717210ORPHA:25151046,XY partial gonadal dysgenesisHP:0040281 - Very frequent2
HP:0010514HP:0011969Elevated circulating luteinizing hormone level2DIAPH2 CL E G H17302877OMIM:300511Premature ovarian failure 2A6
HP:0010514HP:0008232Elevated circulating follicle stimulating hormone level2DIAPH2 CL E G H17302877OMIM:300511Premature ovarian failure 2A6
HP:0010514HP:0008232Elevated circulating follicle stimulating hormone level2DMRT3 CL E G H5852413909ORPHA:25151046,XY partial gonadal dysgenesisHP:0040281 - Very frequent1
HP:0010514HP:0011969Elevated circulating luteinizing hormone level2DMRT3 CL E G H5852413909ORPHA:25151046,XY partial gonadal dysgenesisHP:0040281 - Very frequent1
HP:0010514HP:0008232Elevated circulating follicle stimulating hormone level2ERCC6 CL E G H20743438OMIM:616946PREMATURE OVARIAN FAILURE 11; POF11199
HP:0010514HP:0008232Elevated circulating follicle stimulating hormone level2ESR2 CL E G H21003468OMIM:618187Ovarian dysgenesis 8.
HP:0010514HP:0011969Elevated circulating luteinizing hormone level2ESR2 CL E G H21003468OMIM:618187Ovarian dysgenesis 8.
HP:0010514HP:0011969Elevated circulating luteinizing hormone level2FANCM CL E G H5769723168OMIM:618086Spermatogenic failure 28.107
HP:0010514HP:0008232Elevated circulating follicle stimulating hormone level2FANCM CL E G H5769723168OMIM:618086Spermatogenic failure 28.107
HP:0010514HP:0008232Elevated circulating follicle stimulating hormone level2FGD1 CL E G H22453663OMIM:305400Aarskog-Scott syndrome62
HP:0010514HP:0011969Elevated circulating luteinizing hormone level2FGD1 CL E G H22453663OMIM:305400Aarskog-Scott syndrome62
HP:0010514HP:0011969Elevated circulating luteinizing hormone level2FIGLA CL E G H34401824669OMIM:612310PREMATURE OVARIAN FAILURE 6; POF617
HP:0010514HP:0008232Elevated circulating follicle stimulating hormone level2FIGLA CL E G H34401824669OMIM:612310PREMATURE OVARIAN FAILURE 6; POF617
HP:0010514HP:0008232Elevated circulating follicle stimulating hormone level2FKBP6 CL E G H84683722OMIM:620103
HP:0010514HP:0008232Elevated circulating follicle stimulating hormone level2FOXL2 CL E G H6681092ORPHA:572333Blepharophimosis-ptosis-epicanthus inversus syndrome plusHP:0040283 - Occasional92
HP:0010514HP:0011969Elevated circulating luteinizing hormone level2FOXL2 CL E G H6681092ORPHA:572333Blepharophimosis-ptosis-epicanthus inversus syndrome plusHP:0040283 - Occasional92
HP:0010514HP:0011969Elevated circulating luteinizing hormone level2FSHB CL E G H24883964OMIM:229070Hypogonadotropic hypogonadism 24 without anosmia23
HP:0010514HP:0011969Elevated circulating luteinizing hormone level2GATA4 CL E G H26264173ORPHA:25151046,XY partial gonadal dysgenesisHP:0040281 - Very frequent87
HP:0010514HP:0008232Elevated circulating follicle stimulating hormone level2GATA4 CL E G H26264173ORPHA:25151046,XY partial gonadal dysgenesisHP:0040281 - Very frequent87
HP:0010514HP:0011969Elevated circulating luteinizing hormone level2GCNA CL E G H9395315805OMIM:301077SPERMATOGENIC FAILURE, X-LINKED, 4; SPGFX4
HP:0010514HP:0008232Elevated circulating follicle stimulating hormone level2GCNA CL E G H9395315805OMIM:301077SPERMATOGENIC FAILURE, X-LINKED, 4; SPGFX4
HP:0010514HP:0008232Elevated circulating follicle stimulating hormone level2GDF9 CL E G H26614224OMIM:618014Premature ovarian failure 14.2
HP:0010514HP:0011969Elevated circulating luteinizing hormone level2GDF9 CL E G H26614224OMIM:618014Premature ovarian failure 14.2
HP:0010514HP:0011969Elevated circulating luteinizing hormone level2KISS1R CL E G H846344510OMIM:176400Precocious puberty, central.14
HP:0010514HP:0008232Elevated circulating follicle stimulating hormone level2KISS1R CL E G H846344510OMIM:176400Precocious puberty, central.14
HP:0010514HP:0008232Elevated circulating follicle stimulating hormone level2LHB CL E G H39726584OMIM:228300Hypogonadotropic hypogonadism 23 without anosmia9
HP:0010514HP:0011969Elevated circulating luteinizing hormone level2MAP3K1 CL E G H42146848ORPHA:25151046,XY partial gonadal dysgenesisHP:0040281 - Very frequent13
HP:0010514HP:0008232Elevated circulating follicle stimulating hormone level2MAP3K1 CL E G H42146848ORPHA:25151046,XY partial gonadal dysgenesisHP:0040281 - Very frequent13
HP:0010514HP:0011969Elevated circulating luteinizing hormone level2MCM8 CL E G H8451516147OMIM:612885Premature ovarian failure 10.4
HP:0010514HP:0008232Elevated circulating follicle stimulating hormone level2MCM8 CL E G H8451516147OMIM:612885Premature ovarian failure 104
HP:0010514HP:0008232Elevated circulating follicle stimulating hormone level2MCM9 CL E G H25439421484OMIM:616185Ovarian dysgenesis 44
HP:0010514HP:0008232Elevated circulating follicle stimulating hormone level2MSH4 CL E G H44387327OMIM:619938
HP:0010514HP:0011969Elevated circulating luteinizing hormone level2MSH4 CL E G H44387327OMIM:619938
HP:0010514HP:0008232Elevated circulating follicle stimulating hormone level2MSH5 CL E G H44397328OMIM:617442Premature ovarian failure 135
HP:0010514HP:0011969Elevated circulating luteinizing hormone level2NR0B1 CL E G H1907960ORPHA:25151046,XY partial gonadal dysgenesisHP:0040281 - Very frequent48
HP:0010514HP:0008232Elevated circulating follicle stimulating hormone level2NR0B1 CL E G H1907960ORPHA:25151046,XY partial gonadal dysgenesisHP:0040281 - Very frequent48
HP:0010514HP:0008232Elevated circulating follicle stimulating hormone level2NR5A1 CL E G H25167983ORPHA:25151046,XY partial gonadal dysgenesisHP:0040281 - Very frequent38
HP:0010514HP:0011969Elevated circulating luteinizing hormone level2NR5A1 CL E G H25167983ORPHA:25151046,XY partial gonadal dysgenesisHP:0040281 - Very frequent38
HP:0010514HP:0008232Elevated circulating follicle stimulating hormone level2NR5A1 CL E G H25167983OMIM:61296546XY sex reversal 338
HP:0010514HP:0011969Elevated circulating luteinizing hormone level2NR5A1 CL E G H25167983OMIM:61296546XY sex reversal 338
HP:0010514HP:0011969Elevated circulating luteinizing hormone level2NR5A1 CL E G H25167983OMIM:612964PREMATURE OVARIAN FAILURE 7; POF738
HP:0010514HP:0008232Elevated circulating follicle stimulating hormone level2NR5A1 CL E G H25167983OMIM:612964PREMATURE OVARIAN FAILURE 7; POF738
HP:0010514HP:0011969Elevated circulating luteinizing hormone level2NSMCE2 CL E G H28605326513OMIM:617253Seckel syndrome 10.2
HP:0010514HP:0008232Elevated circulating follicle stimulating hormone level2NSMCE2 CL E G H28605326513OMIM:617253Seckel syndrome 10.2
HP:0010514HP:0008232Elevated circulating follicle stimulating hormone level2POR CL E G H54479208ORPHA:95699Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiencyHP:0040283 - Occasional76
HP:0010514HP:0011969Elevated circulating luteinizing hormone level2POR CL E G H54479208ORPHA:95699Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiencyHP:0040283 - Occasional76
HP:0010514HP:0011969Elevated circulating luteinizing hormone level2PPP2R3C CL E G H5501217485OMIM:618419Gonadal dysgenesis, dysmorphic facies, retinal dystrophy, and myopathy.
HP:0010514HP:0008232Elevated circulating follicle stimulating hormone level2PPP2R3C CL E G H5501217485OMIM:618419Gonadal dysgenesis, dysmorphic facies, retinal dystrophy, and myopathy.
HP:0010514HP:0011969Elevated circulating luteinizing hormone level2PSMC3IP CL E G H2989317928OMIM:614324Ovarian dysgenesis 32
HP:0010514HP:0008232Elevated circulating follicle stimulating hormone level2PSMC3IP CL E G H2989317928OMIM:614324Ovarian dysgenesis 32
HP:0010514HP:0008232Elevated circulating follicle stimulating hormone level2SHOC1 CL E G H15840126535OMIM:619949
HP:0010514HP:0011969Elevated circulating luteinizing hormone level2SOX9 CL E G H666211204ORPHA:25151046,XY partial gonadal dysgenesisHP:0040281 - Very frequent109
HP:0010514HP:0008232Elevated circulating follicle stimulating hormone level2SOX9 CL E G H666211204ORPHA:25151046,XY partial gonadal dysgenesisHP:0040281 - Very frequent109
HP:0010514HP:0011969Elevated circulating luteinizing hormone level2SPIDR CL E G H2351428971OMIM:619665OVARIAN DYSGENESIS 9; ODG92
HP:0010514HP:0008232Elevated circulating follicle stimulating hormone level2SPIDR CL E G H2351428971OMIM:619665OVARIAN DYSGENESIS 9; ODG92
HP:0010514HP:0011969Elevated circulating luteinizing hormone level2SRY CL E G H673611311ORPHA:25151046,XY partial gonadal dysgenesisHP:0040281 - Very frequent23
HP:0010514HP:0008232Elevated circulating follicle stimulating hormone level2SRY CL E G H673611311ORPHA:25151046,XY partial gonadal dysgenesisHP:0040281 - Very frequent23
HP:0010514HP:0008232Elevated circulating follicle stimulating hormone level2SRY CL E G H673611311OMIM:40004546XX sex reversal 1.23
HP:0010514HP:0011969Elevated circulating luteinizing hormone level2SRY CL E G H673611311OMIM:40004546XX sex reversal 1.23
HP:0010514HP:0011969Elevated circulating luteinizing hormone level2SRY CL E G H673611311OMIM:40004446XY sex reversal 1.23
HP:0010514HP:0008232Elevated circulating follicle stimulating hormone level2SRY CL E G H673611311OMIM:40004446XY sex reversal 1.23
HP:0010514HP:0011969Elevated circulating luteinizing hormone level2STAG3 CL E G H1073411356OMIM:615723Premature ovarian failure 84
HP:0010514HP:0008232Elevated circulating follicle stimulating hormone level2STAG3 CL E G H1073411356OMIM:615723Premature ovarian failure 84
HP:0010514HP:0011969Elevated circulating luteinizing hormone level2VAMP7 CL E G H684511486ORPHA:25151046,XY partial gonadal dysgenesisHP:0040281 - Very frequent2
HP:0010514HP:0008232Elevated circulating follicle stimulating hormone level2VAMP7 CL E G H684511486ORPHA:25151046,XY partial gonadal dysgenesisHP:0040281 - Very frequent2
HP:0010514HP:0011969Elevated circulating luteinizing hormone level2WT1 CL E G H749012796ORPHA:25151046,XY partial gonadal dysgenesisHP:0040281 - Very frequent177
HP:0010514HP:0008232Elevated circulating follicle stimulating hormone level2WT1 CL E G H749012796ORPHA:25151046,XY partial gonadal dysgenesisHP:0040281 - Very frequent177
HP:0010514HP:0011969Elevated circulating luteinizing hormone level2WWOX CL E G H5174112799ORPHA:25151046,XY partial gonadal dysgenesisHP:0040281 - Very frequent149
HP:0010514HP:0008232Elevated circulating follicle stimulating hormone level2WWOX CL E G H5174112799ORPHA:25151046,XY partial gonadal dysgenesisHP:0040281 - Very frequent149
HP:0010514HP:0011969Elevated circulating luteinizing hormone level2XRCC2 CL E G H751612829OMIM:619146PREMATURE OVARIAN FAILURE 17; POF17125
HP:0010514HP:0008232Elevated circulating follicle stimulating hormone level2XRCC2 CL E G H751612829OMIM:619146PREMATURE OVARIAN FAILURE 17; POF17125
HP:0010514HP:0011969Elevated circulating luteinizing hormone level2ZFPM2 CL E G H2341416700ORPHA:25151046,XY partial gonadal dysgenesisHP:0040281 - Very frequent31
HP:0010514HP:0008232Elevated circulating follicle stimulating hormone level2ZFPM2 CL E G H2341416700ORPHA:25151046,XY partial gonadal dysgenesisHP:0040281 - Very frequent31
HP:0010514HP:0008232Elevated circulating follicle stimulating hormone level2ZMYND15 CL E G H8422520997OMIM:615842Spermatogenic failure 141
HP:0010514HP:0008232Elevated circulating follicle stimulating hormone level2ZSWIM7 CL E G H12515026993OMIM:619834OVARIAN DYSGENESIS 10; ODG10
HP:0010514HP:0011969Elevated circulating luteinizing hormone level2ZSWIM7 CL E G H12515026993OMIM:619834OVARIAN DYSGENESIS 10; ODG10


Genes (112) :ABCD1 AIP AKT1 AR BAP1 BMP15 BMPR1B BNC1 BRAF C14ORF39 CBX2 CCDC34 CDH23 CDKN1A CDKN1B CDKN2B CDKN2C CFTR CNBP CTNNB1 CYB5A CYP11A1 CYP17A1 DHH DHX37 DIAPH2 DMRT3 ERCC6 ESR1 ESR2 FANCM FGD1 FIGLA FKBP6 FMR1 FOXL2 FSHB FSHR GATA4 GCNA GDF9 GNAS GPR101 HFM1 HPGD HSD17B4 HSD3B2 IGF1 KCNJ11 KISS1R KLHL10 LARS2 LHB LHCGR MAP3K1 MCM4 MCM8 MCM9 MEIOB MEN1 MRPS22 MSH4 MSH5 MSTO1 NANOS1 NF2 NR0B1 NR5A1 NSMCE2 NUP107 PDE11A PDGFB PIK3CA PMM2 PNLDC1 POLA1 POLR3A POLR3H POR PPP2R3C PRKAR1A PRLR PSMC3IP SHOC1 SLCO2A1 SMARCB1 SMARCE1 SMO SOHLH1 SOX9 SPIDR SRY STAG3 SUFU SYCE1 SYCP3 TAF4B TDRD9 TERT TEX11 TEX14 TEX15 TRAF7 TRHR TSHB VAMP7 WT1 WWOX XRCC2 ZFPM2 ZMYND15 ZSWIM7

Diseases (92) :ORPHA:139399 ORPHA:963 OMIM:102200 ORPHA:99725 ORPHA:2965 ORPHA:2495 OMIM:300068 ORPHA:99429 ORPHA:90797 ORPHA:243 OMIM:609441 OMIM:618723 ORPHA:54595 ORPHA:399805 OMIM:619203 OMIM:613080 ORPHA:91347 ORPHA:652 ORPHA:276152 OMIM:610755 OMIM:602668 ORPHA:90796 ORPHA:168558 OMIM:613743 ORPHA:289548 ORPHA:90793 ORPHA:168563 OMIM:273250 ORPHA:251510 OMIM:300511 OMIM:616946 ORPHA:785 OMIM:618187 OMIM:618086 OMIM:305400 OMIM:612310 OMIM:620103 OMIM:311360 OMIM:110100 ORPHA:572333 OMIM:229070 OMIM:233300 ORPHA:64739 OMIM:301077 OMIM:618014 ORPHA:562 OMIM:174800 OMIM:300942 OMIM:300943 OMIM:615724 ORPHA:2796 OMIM:233400 ORPHA:90791 OMIM:608747 ORPHA:79644 OMIM:176400 OMIM:615300 OMIM:228300 OMIM:238320 OMIM:609981 OMIM:612885 OMIM:616185 OMIM:131100 OMIM:619938 OMIM:617442 ORPHA:502423 OMIM:617675 ORPHA:399808 OMIM:612965 OMIM:612964 OMIM:617253 ORPHA:1359 ORPHA:79318 ORPHA:163976 ORPHA:3455 ORPHA:95699 OMIM:618419 OMIM:160980 OMIM:615555 OMIM:614324 OMIM:619949 OMIM:619665 ORPHA:1772 OMIM:400045 OMIM:400044 OMIM:615723 ORPHA:99832 ORPHA:90674 ORPHA:347 OMIM:619146 OMIM:615842 OMIM:619834
 

Human Phenotype Ontology(HPO) is developed by the Human Phenotype Ontology Consortium. The version used here is December 15 2022 release.